Amar Remedies Ltd

Amar Remedies Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Amar Remedies Ltd

₹ 6.07 0.50%
11 Dec 2013
Company website BSE: 532664 NSE: AMAR
About

Amar Remedies Limited, incorporated in India, listed on the Bombay Stock Exchange, and National Stock Exchange Limited, the company is engaged in Manufacuring and Trading of Ayurvedic Products and FMCG.

[ add key points ]
Website BSE NSE
  • Market Cap ₹ Cr.
  • Current Price ₹ 6.07
  • High / Low ₹ /
  • Stock P/E
  • Book Value ₹ 99.8
  • Dividend Yield 0.00 %
  • ROCE 18.7 %
  • ROE 20.6 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Stock is trading at 0.06 times its book value
  • Company has delivered good profit growth of 23.6% CAGR over last 5 years

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: FMCG Industry: Personal Care - Indian

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2011 Dec 2012 Mar 2013 Jun 2013
165 163 131 45
140 145 122 53
Operating Profit 24 18 9 -8
OPM % 15% 11% 7% -18%
1 0 -7 -4
Interest 9 12 14 15
Depreciation 3 5 5 2
Profit before tax 14 2 -16 -29
Tax % 12% 17% 0% 0%
12 1 -16 -29
EPS in Rs 4.69 0.51 -6.17 -11.03
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Jun 2006 Jun 2007 Jun 2008 Jun 2009 Jun 2010 Jun 2011 Jun 2012
167 202 298 369 472 578 674
139 176 263 322 404 496 561
Operating Profit 28 26 35 48 68 82 113
OPM % 17% 13% 12% 13% 14% 14% 17%
0 0 0 2 1 1 -3
Interest 3 4 8 12 21 27 40
Depreciation 1 2 2 7 10 11 13
Profit before tax 24 21 26 30 38 45 57
Tax % 14% 17% 17% 11% 15% 15% 21%
21 17 22 27 32 38 45
EPS in Rs 8.01 6.51 8.32 10.20 12.33 14.54 17.29
Dividend Payout % 0% 0% 0% 10% 8% 7% 0%
Compounded Sales Growth
10 Years: %
5 Years: 27%
3 Years: 22%
TTM: 17%
Compounded Profit Growth
10 Years: %
5 Years: 24%
3 Years: 23%
TTM: 29%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: 20%
3 Years: 20%
Last Year: 21%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Jun 2006 Jun 2007 Jun 2008 Jun 2009 Jun 2010 Jun 2011 Jun 2012
Equity Capital 26 26 26 26 26 26 26
Reserves 64 80 102 126 155 190 235
29 53 56 88 124 249 365
11 24 29 48 57 25 56
Total Liabilities 129 184 213 288 362 490 683
26 29 84 108 115 124 165
CWIP 16 52 0 0 0 11 0
Investments 0 0 0 0 1 1 1
87 102 129 180 246 354 518
Total Assets 129 184 213 288 362 490 683

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Jun 2006 Jun 2007 Jun 2008 Jun 2009 Jun 2010 Jun 2011 Jun 2012
-9 15 2 3 -12 -0 -21
-42 -40 -5 -31 -18 -49 -58
51 24 3 29 33 57 76
Net Cash Flow 0 -0 0 1 3 8 -3

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Jun 2006 Jun 2007 Jun 2008 Jun 2009 Jun 2010 Jun 2011 Jun 2012
Debtor Days 86 87 83 81 83 88 100
Inventory Days 100 95 103 138 111 122 167
Days Payable 6 11 7 14 9 10 11
Cash Conversion Cycle 180 171 179 205 186 199 255
Working Capital Days 157 134 119 127 141 185 230
ROCE % 18% 20% 20% 22% 19% 19%

Shareholding Pattern

Numbers in percentages

Shareholding pattern is currently not available for this company.

Documents

Announcements

Annual reports